Ophthalmology Doctors in Bristol, PA Accepting Medicare

3 Ophthalmology doctors found. Showing 1 - 3

Mark C Montag, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 216 Mill Street, Bristol, PA 19007 Phone: 215-781-2020    Fax: 215-781-6794

Charles Edward Brodowski, Ophthalmology Medicare: Medicare Enrolled Practice Location: 216 Mill St, Bristol, PA 19007 Phone: 215-781-2020

Paul C Keenan Jr., MD Ophthalmology - Cornea and External Diseases Specialist Medicare: Accepting Medicare Assignments Practice Location: 216 Mill St, Bristol, PA 19007 Phone: 215-781-2020    Fax: 215-788-3504

News Archive

Adolescents with sleep issues more likely to use alcohol, marijuana

Adolescents who sleep less or stay up later are significantly more likely to have used alcohol and marijuana over the past month when compared to their peers who report better sleep patterns, according to a new RAND Corporation study.

A New Era in Diabetes Care: Launch of new report

A new expert-led report has today been launched to help outline key challenges and inequalities in the care of type 2 diabetes mellitus (T2DM) and its associated renal and cardiovascular complications, and highlight some Calls to Action to try and address these gaps for the 53 million Europeans living with T2DM.

COVID vaccines have only 17% detectable antibodies against SARS-CoV-2 virus

When clinical trials were conducted to determine the immunogenicity - the ability to elicit an immune response - for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.

Clinical study tests novel topical corneal epithelial stem cell-derived product for treating dry eye disease

Several studies conducted over the last decade have concluded that dry eye disease (DED) affects up to 50% of the U.S. population, creating a liability for the nation's health care system that is estimated to exceed $50 billion annually.

BD MAX Open System for molecular testing launched in Europe

BD Diagnostics, a segment of BD, today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced testing services that elevate the standards of care at their institutions.

Read more Medical News

› Verified 2 days ago